Resveratrol treatment blocks glucose uptake in ovarian cancer cells, triggers starvation-like signalling response (inhibition of Akt/mTOR) and upregulates LMP level resulting in the cytosolic translocation and activation of cathepsin L to promote autophagy-mediated cell death [117,118]. The gene discussed is AKT1; the disease is ovarian carcinoma.